yttrium has been researched along with Barrett Esophagus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kauttu, T; Krogerus, L; Puolakkainen, P; Räsänen, J; Salo, JA; Sihvo, E | 1 |
| Sharma, P; Weston, AP | 1 |
2 other study(ies) available for yttrium and Barrett Esophagus
| Article | Year |
|---|---|
Long-term results of ablation with antireflux surgery for Barrett's esophagus: a clinical and molecular biologic study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aluminum; Barrett Esophagus; CDX2 Transcription Factor; Combined Modality Therapy; Deoxyguanosine; Esophagus; Female; Fundoplication; Gastroesophageal Reflux; Glutathione; Homeodomain Proteins; Humans; Intestinal Mucosa; Laser Therapy; Male; Metaplasia; Oxidative Stress; Peroxidase; Postoperative Complications; Recurrence; Superoxide Dismutase; Treatment Outcome; Tumor Suppressor Protein p53; Yttrium | 2012 |
Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aluminum; Barrett Esophagus; Biopsy; Esophageal Neoplasms; Esophagoscopy; Humans; Laser Therapy; Male; Middle Aged; Neodymium; Yttrium | 2002 |